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Summary
Sparse additive modeling is a class of effective methods for performing high-dimensional nonpara-
metric regression. This paper develops a sparse additive model focused on estimation of treatment
effect-modification with simultaneous treatment effect-modifier selection. We propose a version of
the sparse additive model uniquely constrained to estimate the interaction effects between treat-
ment and pretreatment covariates, while leaving the main effects of the pretreatment covariates
unspecified. The proposed regression model can effectively identify treatment effect-modifiers that
exhibit possibly nonlinear interactions with the treatment variable, that are relevant for making
optimal treatment decisions. A set of simulation experiments and an application to a dataset
from a randomized clinical trial are presented to demonstrate the method.
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1. Introduction
Identification of patient characteristics influencing treatment responses, which are often termed
treatment effect-modifiers or treatment effect-moderators, is a top research priority in precision
medicine. In this paper, we develop a flexible yet simple and intuitive regression approach to
identifying treatment effect-modifiers from a potentially large number of pretreatment patient
characteristics. In particular, we utilize a sparse additive model (Ravikumar and others, 2009)
to conduct effective treatment effect-modifier selection.
The clinical motivation behind the development of a high-dimensional additive regression
model that can handle a large number of pretreatment covariates, specifically designed to model
treatment effect-modification and variable selection, is a randomized clinical trial (Trivedi and
others, 2016) for treatment of major depressive disorder. A large number of baseline patient char-
acterisitics were collected from each participant prior to randomization and treatment allocation.
The primary goal of this study is to discover biosignatures of heterogeneous treatment response.
As we move towards optimizing treatment decisions for individual patients, discovering and iden-
tifying which pretreatment patient characteristics influence treatment effects has the potential to
significantly enhance clinical reasoning in practice (see, e.g., Royston and Sauerbrei, 2008).
The major challenge in efficiently modeling treatment effect-modification from a randomized
clinical trial dataset is that variability due to treatment effect modification (i.e., the treatment-by-
covariates interaction effects on outcomes) is typically dwarfed by a relatively large degree of non-
treatment-related variability (i.e., the main effects of the pretreatment covariates on treatment
outcomes). In particular, in regression, due to potential confounding between the main effect of
the covariates and the treatment-by-covariates interaction effect, misspecification of the covariate
main effect may significantly influence estimation of the treatment-by-covariates interaction effect.
A simple and elegant linear model-based approach to modeling the treatment-by-covariates
interactions, termed the modified covariate (MC) method, that is robust against model misspeci-
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fication of the covariates’ main effects was developed by Tian and others (2014). The method uti-
lizes a simple parameterization and bypasses the need to model the main effects of the covariates.
See also Murphy (2003); Lu and others (2011); Shi and others (2016); Jeng and others (2018) for
the similar linear model-based approaches to estimating the treatment-by-covariates interactions.
However, these approaches assume a stringent linear model to specify the treatment-by-covariates
interaction effects, and are limited to the binary-valued treatment variable case only. In this work,
we extend the optimization framework of Tian and others (2014) for modeling the treatment-by-
covariates interactions using a more flexible regression setting based on additive models (Hastie
and Tibshirani, 1999) that can accommodate more than two treatment conditions, while allowing
an unspecified main effect of the covariates. Additionally, via an appropriate regularization, the
proposed approach simultaneously achieves treatment effect-modifier selection in estimation.
In Section 2, we introduce an additive model that has both the unspecified main effect of the
covariates and the treatment-by-covariates interaction effect additive components. Then we de-
velop an optimization framework specifically targeting the interaction effect additive components
of the model, with a sparsity-inducing regularization parameter to encourage sparsity in the set
of component functions. In Section 3, we develop a coordinate decent algorithm to estimate the
interaction effect part of the model and consider an optimization strategy for estimating indi-
vidualized treatment rules. In Section 4, we illustrate the performance of the method in terms
of treatment effect-modifier selection and estimation of optimal individualized treatment rules
through simulation examples. Section 5 provides an illustrative application from a depression
clinical trial, and the paper concludes with discussion in Section 6.
2. Models
LetA ∈ {1, . . . , L} denote a treatment variable assigned with associated probabilities (pi1, . . . , piL),∑L
a=1 pia = 1, and pia > 0, and let X = (X1, . . . , Xp)
> ∈ Rp denote pretreatment covariates, in-
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dependent of A (as in the case of a randomized trial). If the treatment assignment depends
on the covariates, then the probabilities {pia}a∈{1,...,L} can be replaced by propensity scores
{pia(X)}a∈{1,...,L} which would typically need to be estimated from data. We let Y (a) ∈ R (a =
1,. . . ,L) be the potential outcome if the patient received treatment A = a (a = 1, . . . , L); we only
observe Y = Y (A), A and X.
Throughout the paper, we assume that E[Y |A = a] = 0 (a = 1, . . . , L), without loss of
generality, i.e., the main effect of A on the outcome is centered at 0. This is only to suppress
the treatment a-specific intercepts in regression models in order to simplify the exposition, and
can be achieved by removing the treatment level a-specific means from Y ∈ R. We model the
treatment outcome Y by the following additive model:
E[Y |X, A = a] = µ∗(X)︸ ︷︷ ︸
X “main” effect
+
p∑
j=1
g∗j,a(Xj)︸ ︷︷ ︸
A-by-X interactions
(a = 1, . . . , L) (2.1)
In model (2.1), the first term µ∗(X) does not depend on the treatment variable A and thus
the A-by-X interaction effects are determined only by the second component
∑p
j=1 g
∗
j,A(Xj). In
terms of modeling treatment effect-modification, the term
∑p
j=1 g
∗
j,A(Xj) in (2.1) corresponds to
the “signal” component, whereas the term µ∗(X) corresponds to a “nuisance” component.
In (2.1), for each individual covariate Xj , we utilize a treatment a-specific smooth g
∗
j,a sep-
arately for each treatment condition a ∈ {1, . . . , L}. However, it is useful to treat the set
of treatment-specific smooths for Xj as a single unit, i.e., a single component function g
∗
j =
{g∗j,a}a∈{1,...,L}, for the purpose of treatment effect-modifier variable selection.
In model (2.1), to separate µ∗(X) from the component
∑p
j=1 g
∗
j,a(Xj) and obtain an identi-
fiable representation, without loss of generality, we assume that the set of treatment a-specific
smooths {g∗j,a}a∈{1,...,L} of the jth component function g∗j,A(Xj) satisfies a condition:
E[g∗j,A(Xj)|Xj ] =
L∑
a=1
piag
∗
j,a(Xj) = 0 almost surely, (j = 1, . . . , p). (2.2)
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Condition (2.2) implies E
[∑p
j=1 g
∗
j,A(Xj)|X
]
= 0 almost surely, and separates the A-by-X inter-
action effect component,
∑p
j=1 g
∗
j,a(Xj), from the X “main” effect component, µ
∗(X), in model
(2.1). For model (2.1), we assume Y = E[Y |X, A] + , where  is a zero-mean noise with finite
variance, independent of X and A.
Notation: For a single component j and general (measurable) component functions gj =
{gj,a}a∈{1,...,L}, define the L2 norm of gj as ‖gj‖ =
√
E
[
g2j,A(Xj)
]
, where expectation is
taken with respect to the joint distribution of (A,Xj). (When there is no confusion, we also
use ‖·‖ to denote the L2 norm of a real vector.) For a set of random variables (A,Xj), let
Hj = {gj | E[gj,A(Xj)] = 0, ‖gj‖ < ∞} with inner product on the space defined as 〈gj , fj〉 =
E[gj,A(Xj), fj,A(Xj)]. Sometimes we also write gj := gj,A(Xj) for the notational simplicity.
Under model (2.1) subject to (2.2), the component functions {g∗j , j = 1, . . . , p} associated
with the A-by-X interaction effect can be viewed as the solution to the constrained optimization:
{g∗j } = argmin
{gj∈Hj}
E
[{
Y − µ∗(X)−
p∑
j=1
gj,A(Xj)
}2]
subject to E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p),
(2.3)
where µ∗(X) is given from the assumed model (2.1) (and is considered as fixed in (2.3)). Since
the minimization in (2.3) is in terms of {gj ∈ Hj , j = 1, . . . , p}, the objective function part of the
right-hand side of (2.3) can be reduced to:
arg min
{gj∈Hj}
E
[
Y 2 +
{ p∑
j=1
gj,A(Xj)
}2 − 2{ p∑
j=1
gj,A(Xj)
}
Y + 2
{ p∑
j=1
gj,A(Xj)
}
µ∗(X)
]
= arg min
{gj∈Hj}
E
[
Y 2 +
{ p∑
j=1
gj,A(Xj)
}2 − 2{ p∑
j=1
gj,A(Xj)
}
Y + 2µ∗(X)E
[ p∑
j=1
gj,A(Xj)|X
]]
= arg min
{gj∈Hj}
E
[
Y 2 +
{ p∑
j=1
gj,A(Xj)
}2 − 2{ p∑
j=1
gj,A(Xj)
}
Y
]
,
where the second line is from an application of the iterated expectation rule conditioning on X
and the third line follows from the constraint E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p) on the right-hand
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side of (2.3). Therefore, representation (2.3) can be simplified to:
{g∗j } = argmin
{gj∈Hj}
E
[{
Y −
p∑
j=1
gj,A(Xj)
}2]
subject to E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p),
(2.4)
Representation (2.4) of the component functions {g∗j , j = 1, . . . , p} of the underlying model
(2.1) is particularly useful when the (high-dimensional) “nuisance” function µ∗ in (2.1) is com-
plicated and prone to specification error. Note,
E
[
µ∗(X)
p∑
j=1
gj,A
(
Xj
)]
= E
[
µ∗(X)
p∑
j=1
E
[
gj,A
(
Xj
)|X]] = 0, (2.5)
indicating that the component
∑p
j=1 gj,A
(
Xj
) ∈ H1 + · · · + Hp (subject to the identifiability
constraint E[gj,A(Xj)|Xj ] = 0) is structured to be orthogonal to the X main effect µ∗(X).
This orthogonality property is useful for estimating the additive model A-by-X interaction effect∑p
j=1 g
∗
j,A(Xj), in the presence of the unspecified µ
∗(X) of model (2.1).
Under model (2.1), the potential treatment effect-modifiers among {Xj , j = 1, . . . , p} enter
the model only through the interaction effect term
∑p
j=1 g
∗
j,A(Xj) that associates the treatment
A to the treatment outcome Y . Ravikumar and others (2009) proposed sparse additive modeling
(SAM) for component selection in high-dimensional additive models with a large p. As in SAM, to
deal with a large p and to achieve treatment effect-modifier selection, we impose sparsity on the
set of component functions {g∗j , j = 1, . . . , p} associated with the interaction effect term of model
(2.1), under the often practical and reasonable assumption that most covariates are irrelevant as
treatment effect-modifiers. This sparsity structure on the index set {j} for the nonzero component
functions {g∗j : g∗j 6= 0} can be usefully incorporated into the optimization-based criterion (2.4)
in representing {g∗j }:
{g∗j } = argmin
{gj∈Hj}
E
[{
Y −
p∑
j=1
gj,A(Xj)
}2]
+ λ
p∑
j=1
‖gj‖
subject to E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p),
(2.6)
for a sparsity-inducing parameter λ > 0. The term
∑p
j=1‖gj‖ in (2.6) behaves like an L1 ball
across different components {gj , j = 1, . . . , p} to encourage sparsity in the set of component
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functions. For example, a large value of λ on the right-hand side of (2.6) will generate a sparse
solution with many component functions g∗j on the left-hand side set exactly to zero.
3. Estimation
3.1 Model estimation
For each j, the minimizer g∗j of the optimization problem (2.6) has a component-wise closed-form
expression.
Theorem 3.1 Given λ > 0, the minimizer g∗j ∈ Hj of (2.6) satisfies:
g∗j,A(Xj) =
[
1− λ‖fj‖
]
+
fj,A(Xj) almost surely, (3.7)
where
fj,A(Xj) = E[Rj |Xj , A] − E[Rj |Xj ], (3.8)
in which
Rj = Y −
∑
j′ 6=j
g∗j′,A(Xj′) (3.9)
represents the jth partial residual. In (3.7), Z+ = max(0, Z) represents the positive part of Z.
Note that the fj,A(Xj) correspond to the projections of Rj onto Hj subject to the constraint
in (2.6). The proof of Theorem 3.1 is in the Supplementary Materials.
The component-wise expression (3.7) for g∗j suggests that we can employ a coordinate descent
algorithm (e.g., Tseng, 2001) to solve (2.6). Given a sparsity parameter λ > 0, we can use a
standard backfitting algorithm used in fitting additive models (Hastie and Tibshirani (1999))
that fixes the set of current approximates for g∗j′ at all j
′ 6= j, and obtains a new approximate
of g∗j by equation (3.7), and iterates through all j until convergence. A sample version of the
algorithm can be obtained by inserting sample estimates into the population expressions (3.9),
(3.8) and (3.7) for each coordinate j, which we briefly describe next.
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Given data (Xij , Ai) (i = 1, . . . , n; j = 1, . . . , p), for each j, let Rˆj = Y −
∑
j′ 6=j gˆ
∗
j′,A(Xj′),
corresponding to the data-version of the jth partial residual Rj in (3.9), where gˆ
∗
j′ represents a
current estimate for g∗j′ . We estimate g
∗
j in (3.7) in two steps: 1) estimate the function fj in (3.8);
2) plug the estimate of fj into
[
1− λ‖fj‖
]
+
in (3.7), to obtain the soft-thresholded estimate gˆ∗j .
Although any linear smoothers can be utilized to obtain the estimators {gˆ∗j } as described
in Remark 1 at the end of this section, in this paper, we shall focus on regression spline-type
estimators which are particularly simple and computationally efficient to implement. Specifically,
for each j, the function gj ∈ Hj on the right-hand side of (2.6) will be represented by:
gj,a(Xj) = Ψj(Xj)
>θj,a (a = 1, . . . , L) (3.10)
for some prespecified dj-dimensional basis Ψj(·) ∈ Rdj (e.g., B-spline basis on evenly spaced
knots on a bounded range for Xj) and a set of unknown treatment a-specific basis coefficients
{θj,a ∈ Rdj}a∈{1,...,L}. Given representation (3.10) for the component function gj , the constraint
E[gj,A(Xj)|Xj ] = 0 in (2.6) can be simplified to E[θj,A] =
∑L
a=1 piaθj,a = 0. This constraint can
be written succinctly in a matrix form as
pi(j)θj = 0, (3.11)
where θj := (θ
>
j,1,θ
>
j,2, . . . ,θ
>
j,L)
> ∈ RdjL is the vectorized version of the basis coefficients
{θj,a}a∈{1,...,L} in (3.10), and the dj × djL matrix pi(j) :=
(
pi1Idj ;pi2Idj ; . . . ;piLIdj
)
where Idj
denotes the dj × dj identity matrix.
The restriction of the function gj to the form (3.10) restricts also the minimizer g
∗
j in (3.7)
(note, g∗j,A(Xj) = s
(λ)
j fj,A(Xj), where s
(λ)
j = [1− λ/‖fj‖]+) to the form (3.10). In particular, we
can express the function fj in (3.8) as:
fj,A(Xj) = E[Rj |Xj , A]−
L∑
a=1
piaE[Rj |Xj , A = a]
= Ψj(Xj)θ
∗
j,A −Ψj(Xj)
( L∑
a=1
piaθ
∗
j,a
) (3.12)
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where {θ∗j,a}a∈{1,...,L} := argmin
{θj,a∈Rdj }
E
[{Rj−Ψj(Xj)>θj,A}2]. The first term E[Rj |Xj , A] in (3.12)
corresponds to the L2 projection of the jth partial residual Rj onto the class of functions of
the form (3.10) (without the imposition of the constraint (3.11)), whereas the second term
−∑La=1 piaE[Rj |Xj , A = a] centers the first term to satisfy the linear constraint (3.11). It is
straightforward to verify that fj , as given in (3.12), corresponds to the L
2 projection of Rj onto
the subspace of measurable functions of the form (3.10) subject to the linear constraint (3.11).
Let the n × dj matrices Dj,a (a = 1, . . . , L) denote the evaluation matrices of the basis
function Ψj(·) on Xij (i = 1, . . . , n) specific to the treatment A = a (a = 1, . . . , L), whose
ith row is the 1 × dj vector Ψj(Xij)> if Ai = a, and a row of zeros 0> if Ai 6= a. Then
the column-wise concatenation of the design matrices {Dj,a}a∈{1,...,L}, i.e., the n × djL matrix
Dj = (Dj,1;Dj,2; . . . ;Dj,L), defines the model matrix associated with the vectorized model
coefficient θj ∈ RdjL, vectorized across {θj,a}a∈{1,...,L} in representation (3.10). Then we can
represent the function gj,A(Xj) in (3.10), based on the sample data, by the length-n vector:
gj = Djθj (3.13)
subject to the linear constraint (3.11).
When computing the data version of the function fj in (3.8) which corresponds to the pro-
jection of Rj onto the functional class of (3.10) subject to (3.11), the linear constraint (3.11) on
θj can be conveniently absorbed into the model matrix Dj in (3.13) by reparametrization, as we
describe next. We can find a djL× dj(L− 1) basis matrix Z(j), such that if we set θj = Z(j)θ˜j
for any arbitrary vector θ˜j ∈ Rdj(L−1), then the vector θj ∈ RdjL automatically satisfies the
constraint (3.11) pi(j)θj = 0. Such a basis matrix Z
(j), that spans the null space of the linear
constraint (3.11), can be constructed by a QR decomposition of the matrix pi(j)>. Then repre-
sentation (3.13) can be reparametrized, in terms of the unconstrained vector θ˜j ∈ Rdj(L−1), by
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replacing Dj in (3.13) with the reparametrized model matrix D˜j = DjZ
(j):
gj = D˜j θ˜j . (3.14)
Theorem 3.1 indicates that the coordinate-wise minimizer g∗j of (2.6) can be estimated based
on the sample by
gˆ∗j =
1− λ√
1
n‖fˆj‖2

+
fˆj (3.15)
where
fˆj = D˜j(D˜
>
j D˜j)
−1D˜>j Rˆj (3.16)
in which Rˆj = Y −
∑
j′ 6=j gˆ
∗
j′ is the estimated jth partial residual vector. In (3.15), the norm ‖fj‖
of (3.7) is estimated by the vector norm
√
1
n‖fˆj‖2, and the shrinkage factor (s(λ)j =)
[
1− λ‖fj‖
]
+
of (3.7) is estimated by (sˆ
(λ)
j =)
[
1− λ√
1
n‖fˆj‖2
]
+
.
Based on the sample counterpart (3.15) of the coordinate-wise solution (3.7), a highly efficient
coordinate descent algorithm can be conducted to simultaneously estimate all the component
functions {g∗j , j = 1, . . . , p} in (2.6). At convergence of the coordinate descent, we have a basis
coefficient estimate associated with the representation (3.14),
ˆ˜
θj = sˆ
(λ)
j (D˜
>
j D˜j)
−1D˜>j Rˆj (3.17)
which in turn implies an estimate
θˆj = (θˆ
>
j,1, θˆ
>
j,2, . . . , θˆ
>
j,L)
> = Z(j) ˆ˜θj
for the basis coefficient associated with the representation (3.13). This gives an estimate of the
treatment a-specific function g∗j,a(·) (a = 1, . . . , L) in model (2.1):
gˆ∗j,a(·) = Ψj(·)>θˆj,a (a = 1, . . . , L) (3.18)
estimated within the class of functions (3.10) for a given tuning parameter λ, which controls the
shrinkage factor sˆ
(λ)
j in (3.17). We summarize the computational procedure for the coordinate
descent in Algorithm 1.
Sparse additive models for interactions 11
Algorithm 1 Coordinate descent
1: Input: Data X ∈ Rn × Rp, A ∈ Rn, Y ∈ Rn, and tuning parameter λ.
2: Output: Fitted functions {gˆ∗j , j = 1, . . . , p}.
3: Initialize gˆ∗j = 0 ∀j; pre-compute the smoother matrices D˜j(D˜>j D˜j)−1D˜>j in (3.16) ∀j.
4: while until convergence of {gˆ∗j , j = 1, . . . , p}, do iterate through j = 1, . . . , p:
5: Compute the partial residual Rˆj = Y −
∑
j′ 6=j gˆ
∗
j′
6: Compute fˆj in (3.16); then compute the thresholded estimate gˆ
∗
j in (3.15).
In Algorithm 1, the projection matrices D˜j(D˜
>
j D˜j)
−1D˜>j (j = 1, . . . , p) only need to be
computed once and therefore the coordinate descent can be performed efficiently. In (3.15), if the
shrinkage factor sˆ
(λ)
j =
[
1− λ
√
n
‖fˆj‖
]
+
= 0, the associated jth covariate is absent from the model.
The tuning parameter λ > 0 for treatment effect-modifier selection can be chosen to minimize
an estimate of the expected squared error of the fitted models, E
[{Y −∑pj=1 gˆ∗j,A(Xj)}2], over
a dense grid of λ’s, estimated, for example, by cross-validation. Alternatively, one can utilize the
network information criterion (NIC; Murata and Amari, 1994) which is a generalization of the
Akaike information criterion in approximating the prediction error, for the case where the true
underling model, i.e., model (2.1), is not necessarily in the class of candidate models. Throughout
the paper, λ is chosen to minimize 10-fold cross-validated prediction error of the fitted models.
Remark 1 For coordinate descent, any linear smoothers can be utilized to obtain the sample coun-
terpart (3.15) of the coordinate-wise solution (3.7), i.e., the method is not restricted to regression
splines. To estimate the function fj in (3.8), we can estimate the first term E[Rj |Xj , A = a]
in (3.8), using a 1-dimensional nonparametric smoother for each treatment level a ∈ {1, . . . , L}
separately, based on the data (Rˆij , Xij) (i ∈ {i : Ai = a}) corresponding to the data from the
ath treatment condition; we can also estimate the second term −E[Rj |Xj ] in (3.8) based on the
data (Rˆij , Xij)i∈{1,...,n} which corresponds to the set of data from all treatment conditions, using
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a 1-dimensional nonparametric smoother. Adding these two estimates evaluated at the n ob-
served values of (Xij , Ai) (i = 1, . . . , n) gives an estimate fˆj in (3.15). Then we can compute the
associated estimate gˆ∗j , which allows implementation of the coordinate descent in Algorithm 1.
3.2 Individualized treatment rule estimation
For a single time decision point, an individualized treatment decision rule (ITR), which we denote
by D(X) : Rp 7→ {1, . . . , L}, maps an individual with pretreatment characteristics X to one of
the L treatment options. One natural measure for the effectiveness of an ITR D in precision
medicine is the so-called “value” (V ) function (Murphy, 2005):
V (D) = E[E[Y |X, A = D(X)]], (3.19)
which is the expected treatment response under a given ITR D. If we assume that a larger value
of Y is better (without loss of generality), then the optimal ITR D, which we write as Dopt, can
be naturally defined to be the rule that maximizes the value V (D) (3.19). Such an optimal rule
Dopt satisfies:
Dopt(X) = arg max
a∈{1,...,L}
E[Y |X, A = a] (almost surely). (3.20)
Much work has been carried out to develop methods to estimate the optimal ITR (3.20)
using data from randomized clinical trials. Machine learning approaches to estimating (3.20),
including the outcome weighted learning (e.g., Zhao and others, 2012, 2015; Song and others,
2015) based on support vector machines (SVMs), tree-based classification (e.g., Laber and Zhao,
2015), and adaptive boosting (Kang and others, 2014), among others, are often framed in the
context of a (weighted) classification problem (Zhang and others, 2012; Zhao and others, 2019),
where Dopt(X) in (3.20) is regarded as the optimal classification rule for treatment with respect
to the objective function (3.19).
Under model (2.1), Dopt(X) in (3.20) is: Dopt(X) = arg maxa∈{1,...,L}
∑p
j=1 g
∗
j,a(Xj), which
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can be estimated by: Dˆopt(X) = arg maxa∈{1,...,L}
∑p
j=1 gˆ
∗
j,a(Xj), where gˆ
∗
j,a(·) is given in (3.18)
at the convergence of the Algorithm 1. The proposed approach (2.6), which can be viewed
as a regression-based approach to estimate (3.20), approximates the conditional expectations
E]Y |X, A = a] (a = 1, . . . , L) based on the additive model (2.1), while maintaining robustness
with respect to model misspecification of the “nuisance” function µ∗(·) in (2.1) which is not rel-
evant in estimating Dopt(X) in (3.20). We illustrate the performance of the estimator Dˆopt with
respect to the value function (3.19), through a set of simulation studies in Section 4.2.
3.3 Feature selection and transformation for individualized treatment rules
Although machine learning approaches that attempt to directly maximize (3.19) without as-
suming some specific structure on E]Y |X, A = a] (a = 1, . . . , L) (unlike most of the regression-
based approaches) are highly appealing, common machine learning approaches used in optimizing
ITRs, including SVMs utilized in the outcome weighted learning, are often hard to scale to large
datasets, due to their taxing computational time. In particular, SVMs are viewed as “shallow”
approaches (as opposed to a “deep” learning method that utilizes a learning model with many
representational layers) and successful applications of SVMs often require first extracting useful
representations for their input data manually or through some data-driven feature transforma-
tion (a step called feature engineering) (see, e.g., Kuhn and Johnson, 2019) to have more dis-
criminatory power. Generally, selection and transformation of relevant features can increase the
performance, scale and speed of a machine learning procedure.
As an added value, the proposed regression (2.6) based on model (2.1) provides a practical
feature selection and transformation learning technique for optimizing ITRs. The set of compo-
nent functions {g∗j , j = 1, . . . , p} in (2.6) can be used to define data-driven feature transformation
functions for the original features {Xj , j = 1, . . . , p}. The resulting transformed features can be
used as an input to a machine learning algorithm for optimizing ITRs.
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In particular, we note that for each j, the component function g∗j in (2.6) is defined indepen-
dently from the Xj main effect function µ
∗ in (2.1), and therefore the corresponding transformed
feature variable g∗j,1(Xj), which represents the jth feature Xj in the new space, highlights only
the “signal” nonlinearity in Xj related to the A-by-Xj interactions that is relevant to estimating
Dopt, while excluding the nonlinearity in Xj related to the Xj main effect which is irrelevant to the
ITR development. This “de-noising” procedure for each variable Xj can be often very appealing,
since irrelevant or partially relevant features can negatively impact the performance of a machine
learning algorithm. Moreover, a relatively large value of the tuning parameter λ > 0 in (2.6) would
imply a set of sparse component functions {g∗j }, providing a means of feature selection for ITRs.
For the most common case of L = 2 (binary treatment), we have g∗j,2(Xj) = −pi−12 pi1g∗j,1(Xj)
implied by the constraint (2.2) that we impose, which is simply a scalar-scaling of the function
g∗j,1(Xj); this implies that, for each j, the mapping Xj 7→ g∗j,1(Xj) specifies the feature trans-
formation of Xj . We demonstrate the utility of this feature selection/transformation, which we
use as an input to the outcome weighted learning approach to optimizing ITRs, through a set of
simulation studies in Section 4.2 and a real data application in Section 5.
4. Simulation study
4.1 Treatment effect-modifier selection performance
In this section, we will report simulation results illustrating the performance of the treatment
effect-modifier selection. The complexity of the model for studying the A-by-X interactions can
be summarized in terms of the size of the index set for the component functions {g∗j , j = 1, . . . , p}
that are not identically zero. We can ascertain the performance of a treatment effect-modifier
selection method in terms of these component functions correctly or incorrectly estimated as
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nonzero. To generate the data, we use the following model:
Y =
10∑
j=1
cos(Xj) + (A− 1.5)X1 + 2(A− 1.5) cos(X2) +  A ∈ {1, 2}, (4.21)
where Xj (j = 1, . . . , p), p ∈ {50, 100}, is generated from independent Unif[−pi/2, pi/2], and
the treatment variable A ∈ {1, 2} is generated independently of X and the error term  ∼
N (0, 0.52), such that Pr(A = 1) = Pr(A = 2) = 1/2. Under model (4.21), there are only 2
true treatment effect-modifiers, X1 and X2. In terms of model (2.1), we can write the A-by-
X interaction effect component functions for model (4.21) as: g∗1,A(X1) = (A − 1.5)X1 and
g∗2,A(X2) = 2(A−1.5) cos(X2), and g∗j,A(Xj) = 0 (j = 3, . . . , p), i.e., the other p−2 covariates are
“noise” covariates, that are not consequential for optimizing ITRs. Also, in (4.21), there are 10
covariates Xj (j = 1, . . . , 10), among the p covariates, associated with the X main effects. Under
this setting, the contribution to the variance of the outcome from the X main effect component
was about 2 times larger than that from the interaction effect component.
We consider two approaches to treatment effect-modifier selection: 1) the proposed additive
regression approach (2.6) that specifies a sparse set of functions {g∗j , j = 1, . . . , p}, estimated
via Algorithm 1, with the dimension of the cubic B-spline basis Ψj in (3.10) set to be dj = 6
(j = 1, . . . , p); and 2) the linear regression (MC) approach of Tian and others (2014),
minimize
{βj∈R}
E
[{
Y −
p∑
j=1
(A− 1.5)Xjβj
}2]
+ λ
p∑
j=1
|βj |, (4.22)
which specifies a sparse vector β∗ = (β∗1 , . . . , β
∗
p)
> ∈ Rp. Given each simulated dataset, the tuning
parameter λ > 0 is chosen to minimize a 10-fold cross-validated prediction error.
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Fig. 1. The proportion of the relevant covariates (i.e., the treatment effect-modifiers) correctly selected
(the “true positives”; left two panels), and the irrelevant covariates (i.e., the noise covariates) incorrectly
selected (the “false positives”; right two panels), respectively (and ±1 standard deviation), as the training
sample size n varies from 50 to 500, for each p ∈ {50, 100}. Two methods were compared: 1) the proposed
additive model (solid curves), and 2) the linear model (MC) approach (dashed curves).
Figure 1 summarizes the results of the treatment effect-modifier selection performance with
respect to the true/false positive rates (the left/right two panels, respectively), comparing the
proposed additive regression to the linear regression approach, which are reported as the averages
(and ±1 standard deviations) across the 200 simulation replications. Figure 1 illustrates that, for
the both p = 50 and p = 100 cases, the proportion of the correctly selecting treatment effect-
modifiers (i.e., the “true positive”; the left two panels) of the additive regression method (the
red solid curves) tends to 1, with n increasing from n = 50 to n = 500, while the proportion
of incorrectly selecting treatment effect-modifiers (i.e., the “false positive”; the right two panels)
tends to be bounded above by a small number. On the other hand, the proportion of correctly
selecting treatment effect-modifiers for the linear regression method (the blue dotted curves)
tends to be only around 0.5 for both choices of p. The linear regression method selects only
one treatment effect-modifier X1 which has a linear interaction effect with A, while generally
not selecting the other treatment effect-modifier X2, i.e., the one that has the nonlinear (cosine)
interaction effect (see (4.21) for the setting) with A.
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4.2 Individualized treatment rule estimation performance
In this subsection, we assess the optimal ITR estimation performance of the proposed method
based on simulations. We generate a vector of covariatesX = (X1, . . . , Xp)
> ∈ Rp based on a mul-
tivariate normal distribution with each component having the marginal distribution N (0, (pi/2)2)
with the correlation between the components corr(Xj , Xk) = 0.1
|j−k|. In this illustration, we
consider p = 50. Responses were generated, for 1) “nonlinear” A-by-X interactions:
Y = δ
5∑
j=1
sin(Xj) + 2(A− 1.5)
{
cos(X1)− cos(X2) + ξ sin(X1X2)
}
+  A ∈ {1, 2}, (4.23)
and for 2) “linear” A-by-X interactions:
Y = δ
5∑
j=1
sin(Xj) + (A− 1.5)
{
X1 −X2 + ξX1X2
}
+  A ∈ {1, 2}, (4.24)
where the treatment variable A ∈ {1, 2} is generated independently from the covariates X and
the error term  ∼ N (0, 0.52), such that Pr(A = 1) = Pr(A = 2) = 1/2. Models (4.23) and (4.24)
are indexed by a pair {δ, ξ}. The parameter δ ∈ {1, 2} controls the proportion of the variance of
the response Y attributable to the X “main” effect: δ = 1 corresponds to a moderate X main
effect contribution; δ = 2 corresponds to a large X main effect contribution. Estimation of the
interaction effect becomes more difficult with a larger δ. The parameter ξ ∈ {0, 1} determines
whether the A-by-X interaction effect term has an exact additive regression structure (ξ = 0) or
whether it deviates from an additive structure (ξ = 1). In the case of ξ = 0, the proposed model
(2.1) is correctly specified, whereas, for the case of ξ = 1, model (2.1) is misspecified. For each
scenario, we consider the following four approaches to estimating the optimal ITR Dopt in (3.20).
1. The proposed additive regression approach (2.6), estimated via Algorithm 1. The dimension
of the basis function Ψj in (3.10) is taken to be dj = 6 (j = 1, . . . , p). Given estimates {gˆ∗j },
the estimate of Dopt in (3.20) is Dˆopt(X) = arg maxa∈{1,...,L}
∑p
j=1 gˆ
∗
j,a(Xj).
2. The linear regression (MC) approach (4.22) of Tian and others (2014), implemented through
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the R-package glmnet, with the sparsity tuning parameter λ selected by minimizing a 10-
fold cross-validated prediction error. Given an estimate βˆ∗ = (βˆ∗1 , . . . , βˆ
∗
p)
>, the correspond-
ing estimate of Dopt in (3.20) is Dˆopt(X) = arg maxa∈{1,...,L}
∑p
j=1(a− 1.5)Xj βˆ∗j .
3. The outcome weighted learning (OWL) method (Zhao and others, 2012) based on a Gaus-
sian radial kernel, implemented in the R-package DTRlearn, with a set of feature trans-
formed (FT) covariates {gˆ∗j,1(Xj), j = 1, . . . , p} used as an input to the OWL method, in
which the functions gˆ∗j,1(·) (j = 1, . . . , p) are obtained from the approach in 1. To improve the
efficiency of the OWL, we employ the augmented OWL approach of Liu and others (2018).
The inverse bandwidth parameter σ2n and the tuning parameter κ in Zhao and others (2012)
are chosen from the grid of (0.01, 0.02, 0.04, . . . , 0.64, 1.28) and that of (0.25, 0.5, 1, 2, 4) (the
default setting of DTRlearn), respectively, based on a 5 fold cross-validation.
4. The same (OWL) approach as in 3 but based on the original features {Xj , j = 1, . . . , p}.
For each simulation run, we estimate Dopt from each of the four methods based on a training
set (of size n ∈ {250, 500}), and for evaluation of these methods, we compute the value V (Dˆopt)
in (3.19) for each estimate Dˆopt, using a Monte Carlo approximation based on a random sample
of size 103. Since we know the true data generating model in simulation studies, the optimal
Dopt can be determined for each simulation run. Given each estimate Dˆopt of Dopt, we report
V (Dˆopt)−V (Dopt), as the performance measure of Dˆopt. A larger value (i.e., a smaller difference
from the optimal value) of the measure indicates better performance.
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Fig. 2. Boxplots obtained from 100 Monte Carlo simulations comparing 4 approaches to estimating Dopt,
given each scenario indexed by ξ ∈ {0, 1}, δ ∈ {1, 2} and n ∈ {250, 500}, for the nonlinear A-by-X
interaction effect case in the top panels, and the linear A-by-X interaction effect case in the bottom
panels. The dotted horizontal line represents the optimal value corresponding to Dopt.
In Figure 2, we present the boxplots, obtained from 100 simulation runs, of the normalized
values V (Dˆopt) (normalized by the optimal values V (Dopt)) of the decision rules Dˆopt estimated
from the four approaches, for each combination of n ∈ {250, 500}, ξ ∈ {0, 1} (corresponding to
correctly-specified or mis-specified additive interaction effect models, respectively) and δ ∈ {1, 2}
(corresponding to moderate or large main effects, respectively), for the nonlinear and the linear
A-by-X interaction effect scenarios, in the top and bottom panels, respectively. The proposed
additive regression clearly outperforms the OWL (without feature transformation) method in
all scenarios (both the top and bottom panels), and the linear regression approach in all of the
nonlinear A-by-X interaction effect scenarios (the top panels). For the linear A-by-X interaction
effect scenarios (the bottom panels), when ξ = 0 (i.e., when the linear interaction model is
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correctly specified), the linear regression outperforms the additive regression, but only slightly,
whereas if the underlying model deviates from the exact linear structure (i.e., ξ = 1 in model
(4.24)) and n = 500, the more flexible additive regression tends to outperform the linear model.
This suggests that, in the absence of prior knowledge about the form of the interaction effect,
for optimizing ITRs, employing the proposed additive regression is more suitable than the linear
regression. Comparing the two OWL methods (OWL (FT) and OWL), Figure 2 illustrates that
the feature transformation provides a considerable benefit in their performance. This suggests the
utility of the estimated component functions {gˆ∗j , j = 1, . . . , p} of the proposed additive model
as a potential feature transformation and selection tool for a machine learning algorithm for
optimizing ITRs. Comparing the cases with δ = 2 to those with δ = 1, the increased magnitude
of the main effect generally dampens the performance of all approaches, as the “noise” variability
in the data generation model increases.
5. Application to data from a depression clinical trial
In this section, we illustrate the utility of the proposed additive regression for estimating treat-
ment effect-modification and optimizing individualized treatment rules, using data from a depres-
sion clinical trial study, comparing an antidepressant and placebo for treating major depressive
disorder (Trivedi and others, 2016). The goal of the study is to identify baseline characteristics
that are associated with differential response to the antidepressant versus placebo and to use
those characteristics to guide treatment decisions when a patient presents for treatment.
Study participants (a total of n = 166 participants) were randomized to either placebo (A = 1;
n1 = 88) or an antidepressant (sertraline) (A = 2; n2 = 78). Subjects were monitored for 8 weeks
after initiation of treatment, and the primary endpoint of interest was the Hamilton Rating Scale
for Depression (HRSD) score at week 8. The outcome Y was taken to be the improvement in
symptoms severity from baseline to week 8, taken as the difference, i.e., we take: week 0 HRSD
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score - week 8 HRSD score. (Larger values of the outcome Y are considered desirable.) The study
collected baseline patient clinical data, prior to treatment assignment. These pretreatment clinical
dataX = (X1, X2, . . . , X13)
> ∈ R13 include: X1 = Age at evaluation; X2 = Severity of depressive
symptoms measured by the HRSD at baseline; X3 = Logarithm of duration (in month) of the
current major depressive episode; and X4 = Age of onset of the first major depressive episode.
In addition to these standard clinical assessments, patients underwent neuropsychiatric testing
at baseline to assess psychomotor slowing, working memory, reaction time (RT) and cognitive
control (e.g., post-error recovery), as these behavioral characteristics are believed to correspond
to biological phenotypes related to response to antidepressants (Petkova and others, 2017) and
are considered as potential modifiers of the treatment effect. These neuropsychiatric baseline test
measures include: X5 = (A not B) RT-negative; X6 = (A not B) RT-non-negative; X7 =(A not
B) RT-all; X8 = (A not B) RT-total correct; X9 = Median choice RT; X10 = Word fluency;
X11 = Flanker accuracy; X12 = Flanker RT; X13 = Post conflict adjustment.
The proposed approach (2.6) to estimating the A-by-X interaction effect part
∑p
j=1 g
∗
j,A(Xj)
of model (2.1), estimated via Algorithm 1, simultaneously selected 3 pretreatment covariates
as treatment effect-modifiers: X1 (“Age at evaluation”), X10 (“Word fluency test”) and X11
(“Flanker accuracy test”). Figure 3 illustrates the estimated non-zero component functions {gˆ∗j 6=
0, j = 1, . . . , 13} (i.e., the component functions corresponding to the selected covariates X1, X10
and X11) and the associated partial residuals. The linear regression approach (4.22) to estimating
the A-by-X interactions selected a single covariate, X11, as a treatment effect-modifier.
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Fig. 3. Scatterplots of partial residuals vs. the covariates associated with estimated non-zero component
functions {gˆ∗j 6= 0} for placebo (blue circles) and the active drug (red triangles) treated participants. For
each panel, the blue dashed curve represents gˆ∗j,1(·), corresponding to the placebo (a = 1), and the red
solid curve represents gˆ∗j,2(·), corresponding to the active drug (a = 2).
To evaluate the performance of the ITRs (Dˆopt) obtained from the four different approaches
described in Section 4.2, we randomly split the data into a training set and a testing set (of size
n˜) using a ratio of 5 to 1, replicated 500 times, each time computing an ITR Dˆopt based on the
training set, then estimating its value V (Dˆopt) in (3.19) by an inverse probability weighted esti-
mator (Murphy, 2005): Vˆ (Dˆopt) = ∑n˜i=1 YiI(Ai=Dˆopt(Xi))/∑n˜i=1 I(Ai=Dˆopt(Xi)), computed based
on the testing set of size n˜. For comparison, we also include two na¨ıve rules: treating all patients
with placebo (“All PBO”) and treating all patients with the active drug (“All DRUG”), each
regardless of the individual patient’s characteristics X. The resulting boxplots obtained from
the 500 random splits are illustrated in Figure 4. A larger value of the measure indicates better
performance.
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Fig. 4. Boxplots of the estimated values of the treatment rules Dˆopt estimated from 6 approaches, obtained
from 500 randomly split testing sets. Higher values are preferred.
The results in Figure 4 demonstrate that the proposed additive regression approach, which al-
lows nonlinear flexibility in developing ITRs, tends to outperform the linear regression approach,
in terms of the estimated value. The additive regression approach also shows some superiority
over the method OWL (without feature transformation). In comparison to the OWL methods,
the proposed additive regression, in addition to its superior computational efficiency, provides a
means of simultaneously selecting treatment effect-modifiers and allows a visualization for the het-
erogeneous effects attributable to each estimated treatment effect-modifier as in Figure 3, which is
an appealing feature in practice. Moreover, the estimated component functions {gˆ∗j , j = 1, . . . , p}
of the proposed regression provide an effective means of performing feature transformation for
{Xj , j = 1, . . . , p}. As in Section 4.2, the feature transformed OWL approach appears to have a
considerable improvement over the OWL that bases on the original untransformed covariates.
6. Discussion
In this paper, we have developed a sparse additive model, via a structural constraint, specifi-
cally geared to identify and model treatment effect-modifiers. The approach utilizes an efficient
back-fitting algorithm for model estimation and variable selection. The proposed sparse additive
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model for treatment effect-modification extends existing linear model-based regression methods
by providing nonlinear flexibility to modeling treatment-by-covariate interactions. Encouraged
by our simulation results and the application, future work will investigate the asymptotic prop-
erties related to treatment effect-modifier selection and estimation consistency, in addition to
developing hypothesis testing procedures for treatment-by-covariates interaction effects.
Modern advances in biotechnology, using measures of brain structure and function obtained
from neuroimaging modalities (e.g., MRI, fMRI and EEG), show the promise of discovering
potential biomarkers for heterogeneous treatment effects. These high dimensional data modalities
are often in the form of curves or images and can be viewed as functional data (e.g., Ramsay and
Silverman, 1997). Future work will also extend the additive model approach to the context of
functional additive regression (e.g., Fan and others, 2015, 2014). The goal of these extensions will
be to handle a large number of functional-valued covariates while achieving simultaneous variable
selection, which will extend current functional linear model-based methods for precision medicine
(McKeague and Qian, 2014; Ciarleglio and others, 2015, 2018) to a more flexible functional
regression setting.
7. Software
R-package samTEMsel (Sparse Additive Models for Treatment Effect-Modifier Selection) contains
R-codes to perform the methods proposed in the article, and is publicly available on GitHub
(syhyunpark/samTEMsel).
8. Supplementary Materials
The Supplementary Materials including the proof of Theorem 3.1 and the R-codes and the dataset
used in this article are available online at http://biostatistics.oxfordjournals.org.
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Proof of Theorem 1
Proof. The squared error criterion on the right-hand side of (2.6) of the main manuscript is
E
[{
Y −
p∑
j=1
gj,A(Xj)
}2] ∝ E[Y p∑
j=1
gj,A(Xj)−
{ p∑
j=1
gj,A(Xj)
}2
/2
]
(with respect to {gj})
= E
[{
µ∗(X) +
p∑
j=1
g∗j,A(Xj)
} p∑
j=1
gj,A(Xj)−
{ p∑
j=1
gj,A(Xj)
}2
/2
]
= E
[
µ∗(X)
p∑
j=1
gj,A(Xj)
]
+ E
[{ p∑
j=1
g∗j,A(Xj)
}{ p∑
j=1
gj,A(Xj)
}− { p∑
j=1
gj,A(Xj)
}2
/2
]
= E
[{ p∑
j=1
g∗j,A(Xj)
}{ p∑
j=1
gj,A(Xj)
}− { p∑
j=1
gj,A(Xj)
}2
/2
]
,
(8.25)
where the last equality follows from the constraint E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p) in (2.6) of the
main manuscript imposed on {gj}, and by noting E
[
µ∗(X)
∑p
j=1 gj,A
(
Xj
)]
= E
[
E
[
µ∗(X)
∑p
j=1 gj,A(Xj)|X
]]
=
E
[
µ∗(X)
∑p
j=1 E
[
gj,A(Xj)|Xj
]]
= 0. From (8.25), the squared error criterion in (2.6) of the main
manuscript can be expressed as:
argmin
{gj∈Hj}
E
[(
Y −
p∑
j=1
gj,A
(
Xj
))2]
= argmin
{gj∈Hj}
E
[( p∑
j=1
g∗j,A
(
Xj
)− p∑
j=1
gj,A
(
Xj
))2]
. (8.26)
In the following, we closely follow the proof of Theorem 1 in Ravikumar and others (2009). The
constrained objective function in (2.6) of the main manuscript can be rewritten in Lagrangian
form as:
Q({gj};λ) := E
[( p∑
j=1
g∗j,A(Xj)−
p∑
j=1
gj,A(Xj)
)2]
+ λ
p∑
j=1
‖gj‖ (8.27)
For the notational simplicity, let us write gj = gj,A(Xj). For each j, consider the minimization of
(8.27) with respect to the component function gj ∈ Hj , holding the other component functions
{gj′ , j′ 6= j} fixed. The stationary condition is obtained by setting its Fre´chet derivative to 0.
Denote by ∂jQ({gj};λ; ηj) the directional derivative with respect to gj (j = 1, . . . , p) in the
direction, say, ηj ∈ Hj . Then, the stationary point of the Lagrangian (8.27) can be formulated
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as:
∂jQ({gj};λ; ηj) = 2E
[
(gj − R˜j + λνj)ηj
]
= 0, (8.28)
where
R˜j :=
p∑
j=1
g∗j,A(Xj)−
∑
j′ 6=j
gj′,A(Xj) (8.29)
is the partial residual for gj , and νj is an element of the subgradient ∂‖gj‖, which satisfies
νj = gj/‖gj‖ if ‖gj‖ 6= 0, and νj ∈ {s ∈ Hj | ‖s‖ 6 1}, otherwise. Using iterated expectations
conditional on Xj and A, (8.28) can be rewritten as
2E
[(
gj − E
[
R˜j |Xj , A
]
+ λνj
)
ηj
]
= 0. (8.30)
Since gj − E
[
R˜j |Xj , A
]
+ λνj ∈ Hj , we can evaluate (8.28) (i.e., (8.30)) in the direction: ηj =
gj − E
[
R˜j |Xj , A
]
+ λνj , implying E
[(
gj − E
[
R˜j |Xj , A
]
+ λνj
)2]
= 0. This implies:
gj + λνj = E
[
R˜j |Xj , A
]
(almost surely). (8.31)
Let fj denote the right-hand side of (8.31), i.e., fj(= fj,A(Xj)) := E
[
R˜j |Xj , A
]
. If ‖gj‖ 6= 0,
then νj = gj/‖gj‖. Therefore, by (8.31), we have ‖fj‖ = ‖gj +λgj/‖gj‖‖ = ‖gj‖+λ > λ. On the
other hand, if ‖gj‖ = 0, then gj = 0 (almost surely) and ‖νj‖ 6 1 which, together with condition
(8.31), implies that ‖fj‖ 6 λ. This gives us the equivalence between ‖fj‖ 6 λ and the statement
gj = 0 (almost surely). Therefore, condition (8.31) leads to the following expression:
(1 + λ/‖gj‖) gj = fj (almost surely)
if ‖fj‖ > λ; otherwise, and gj = 0 (almost surely). This gives the soft thresholding update rule
for gj .
The underlying model (2.1) of the main manuscript indicates that
∑p
j=1 g
∗
j,A(Xj) = E[Y |X,A]−
µ∗(X). Thus, (8.29) can be equivalently written as: R˜j = E[Y |X,A]−µ∗(X)−
∑
j′ 6=j gj′,A(Xj′).
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Therefore, the function fj,A(Xj) = E
[
R˜j |Xj , A
]
can be written by:
fj,A(Xj) = E
[
E[Y |X,A]− µ∗(X)−
∑
j′ 6=j
gj′,A(Xj′) | Xj , A
]
= E
[
E[Y |X,A]−
∑
j′ 6=j
gj′,A(Xj′)|Xj , A
]− E[µ∗(X)|Xj , A]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xj′)|Xj , A
]− E[µ∗(X)|Xj]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xj′)|Xj , A
]− E[µ∗(X) + p∑
j=1
g∗j,A
(
Xj
)|Xj]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xj′)|Xj , A
]− E[Y |Xj]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xj′)|Xj , A
]− E[Y −∑
j′ 6=j
gj′,A(Xj′)|Xj
]
= E
[
Rj |Xj , A
]− E[Rj |Xj],
where the fourth equality follows from the identifiability constraint (2.2) of the underlying model
(2.1) of the main manuscript, and the sixth equality follows from the optimization constraint
E[gj,A(Xj)|Xj ] = 0 (j = 1, . . . , p) in (2.6) of the main manuscript imposed on {gj}; this gives the
desired expression (3.8) of the main manuscript.
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